FDA published a revision to MAPP

Click on the link below to read about how the FDA published a revision to the Manual of Policies and Procedures on ANDAs to ensure fairness to applicants and much more..

FDA revises generic drug application prioritization

And after you read about the revision head on over to Compliance Insight to see how we can help you with all of your FDA filings!

16 views0 comments

Gain Our Insight


Be in Touch


e. info@compliance-insight.com

p. (513) 860 - 3512

© 2020 by Compliance Insight

All Rights Reserved  |  Contact Us

Corporate Headquarters


497 Circle Freeway Suite 230

Cincinnati, Ohio 45246

Business Hours


Monday - Friday 

8:30am EST - 5:30pm EST

  • facebook
  • linkedin
  • twitter
  • youtube